Ganti, A. K., Snider, J., Yan, J., Rinaldi, C., Nguyen, A., Rengarajan, B., Profant, D. A., Fuller, D. S., Hu, E., Le, T. K., Naveh, N., Fan, X. (2026). Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first-line induction and maintenance regimens in extensive-stage small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8093